CORV : Correvio Pharma Corp Stock Profile

Last Updated: 3/12/2024 0:47:16

Correvio Pharma Corp trades with the ticker CORV on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.

Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. Its products comprise Aggrastat (tirofiban hydrochloride), (an intravenous anti-platelet drug for patients with acute coronary syndrome; and Brinavess (vernakalant IV), a novel, atrial-preferential antiarrhythmic agent for the rapid conversion of recent onset atrial fibrillation to sinus rhythm. The company also offers Trevyent, a development stage drug/device combination product for pulmonary arterial hypertension; Xydalba, a treatment for acute bacterial skin and skin structure infections; and Zevtera/Mabelio, a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria. Correvio Pharma Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.

Looking to invest in Correvio Pharma Corp? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.

CORV.TO Stock Price and Key Stats

ETF Key Stats

Exchange: TSX

Market Cap : $37.067MM

PE Ratio:

Price: #N/A (Updated: 3/12/2024 0:47:16)

Correvio Pharma Corp (CORV) vs Competitors in Drug Manufacturers – Specialty & Generic

Lets see how CORV.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:

Aleafia Health Inc, Aphria Inc, Acerus Pharmaceuticals Corporation, The Supreme Cannabis Company, Inc, Nuvo Pharmaceuticals Inc


Drug Manufacturers – Specialty & Generic Industry Comparisons

Company Market Cap ($MM) P/E Ratio EV/EBITDA Dividend Yield
Aleafia Health Inc (ALEF) $189.563 N/A 0.0 0.0%
Aphria Inc (APHA) $4,439.753 N/A 598.009 0.0%
Acerus Pharmaceuticals Corporation (ASP) $2.775 N/A -2.796 0.0%
Correvio Pharma Corp (CORV) $37.067 N/A 0.0 0.0%
The Supreme Cannabis Company, Inc (FIRE) $255.583 N/A 0.0 0.0%

EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield  

Comparisons within Drug Manufacturers – Specialty & Generic

  • Correvio Pharma Corp (CORV) vs Aleafia Health Inc (ALEF)
    • ALEF has higher EPS (-0.274 vs -0.879). ALEF has higher dividend yield (0.0% vs 0.0%). ALEF and CORV both have P/E’s under 0.
  • Correvio Pharma Corp (CORV) vs Aphria Inc (APHA)
    • APHA has higher EPS (0.116 vs -0.879). APHA has higher dividend yield (0.0% vs 0.0%). APHA and CORV both have P/E’s under 0.
  • Correvio Pharma Corp (CORV) vs Acerus Pharmaceuticals Corporation (ASP)
    • CORV has higher EPS (-0.879 vs -4.41). ASP has higher dividend yield (0.0% vs 0.0%). ASP and CORV both have P/E’s under 0.
  • Correvio Pharma Corp (CORV) vs The Supreme Cannabis Company, Inc (FIRE)
    • FIRE has higher EPS (-0.052 vs -0.879). FIRE has higher dividend yield (0.0% vs 0.0%). FIRE and CORV both have P/E’s under 0.
  • Correvio Pharma Corp (CORV) vs Nuvo Pharmaceuticals Inc (NRI)
    • NRI has higher EPS (0.024 vs -0.879). NRI has higher dividend yield (0.0% vs 0.0%). CORV has a P/E under 0, indicating NRI (P/E 2.6) is in a better position.

Our Recommendation: Hold
Features a lower EV/EBITDA ratio (0.00) than the industry average (2.71), indicating attractive valuation.

How to Buy CORV stock on the TSX

You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:

ImageProduct TitleFeaturesPrice
Editor's Choice
Wealthsimple Trade

Wealthsimple Trade

  • ETF buys and sells have $0 trading fees
  • Desktop and mobile trading
  • Reputable Brand
  • Beautiful Design
Get $25 Signup Bonus
Reliable Pick


  • ETF buys have $0 trading fees
  • Desktop and mobile trading
  • Most types of accounts available
Get $50 Free Stock Trades
Photo of author
Author Bio - Qayyum Rajan is a CFA Charterholder with 10+ years of finance experience and the co-creator of He has previously worked as a portfolio manager at RBC Dominion Securities and other roles at asset managers like Sentry Investments. He then started building websites and fintech apps to bring finance to everyone.

Check Out These Posts:

Leave a Comment